| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Roy Castle International Centre for Lung Cancer Research, Molecular Oncology Unit, Liverpool L3 9TA [T. L., P. M., G. X., M. H., J. K. F.]; Departments of Clinical Dental Sciences L69 3BX [T. L., P. M., G. X., M. H., J. K. F.] and Pathology, Liverpool L69 3GA [J. R. G., L. T.], University of Liverpool; and Cardiothoracic Centre, Liverpool L14 3PE 4 [M. J. W.], United Kingdom
We examined genomic instability in DNA from 80 bronchial lavage samples from patients with lung cancer and individuals with no malignant lung disease. We used a multiplex assay of eight fluorescent-tagged microsatellite markers that have a very high incidence of allelic imbalance in lung tumors. When genomic instability at individual loci was analyzed statistically against diagnosis, markers D3S1289 (P = 0.033), D3S1300 (P = 0.001), D13S171 (P = 0.009), and D17S2179E (P = 0.017) demonstrated significantly higher frequency of instability in bronchial lavage specimens from lung cancer cases than those with nonmalignant conditions. In contrast, markers D9S157, D9S161, D13S153, and D5S644 demonstrated lower specificity (P > 0.05) for lung tumors. These results suggest that genomic instability in some loci may be related to high proliferation rates but not necessarily to cell commitment to malignancy. When genomic instability was scored with only the four cancer-specific markers, the assay produced a sensitivity of 73.9% and a specificity of 76.5%. On combining the results from the cytological examination and the molecular assay, the sensitivity reached 82.6%. These results indicate that in our efforts to investigate genomic instability as a potential marker for the early detection of lung cancer, we need to identify cancer-specific genomic instability markers. This paper has shown that these first four markers may be considered to form an individual set of cancer-specific genomic instability markers.
This article has been cited by other articles:
![]() |
A. K. Ganti and J. L. Mulshine Lung cancer screening. Oncologist, May 1, 2006; 11(5): 481 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.K. Field and C. Brambilla Major conceptual change required to improve lung cancer: see a respiratory physician Eur. Respir. J., April 1, 2003; 21(4): 565 - 566. [Full Text] [PDF] |
||||
![]() |
T.-L. Tseng, Y.-P. Shih, Y.-C. Huang, C.-K. Wang, P.-H. Chen, J.-G. Chang, K.-T. Yeh, Y.-M. A. Chen, and K. H. Buetow Genotypic and Phenotypic Characterization of a Putative Tumor Susceptibility Gene, GNMT, in Liver Cancer Cancer Res., February 1, 2003; 63(3): 647 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Miturski, M. Bogusiewicz, C. Ciotta, M. Bignami, M. Gogacz, and D. Burnouf Mismatch Repair Genes and Microsatellite Instability as Molecular Markers for Gynecological Cancer Detection Experimental Biology and Medicine, September 1, 2002; 227(8): 579 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Belgrader, F. Raisi, R. Joshi, P. Nguyen, W. McMillan, J. Ching, R. Chang, and M. A. Northrup Rapid and Automated Cartridge-based Extraction of Leukocytes from Whole Blood for Microsatellite DNA Analysis by Capillary Electrophoresis Clin. Chem., October 1, 2001; 47(10): 1929 - 1931. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |